Mechanism of Action of Morphine


Introduction

Morphine is a potent opioid analgesic derived from opium and widely used for the management of moderate to severe pain. It acts primarily on opioid receptors in the central nervous system to produce analgesia, sedation, and euphoria. Morphine is considered the prototype opioid and is commonly used in postoperative pain, cancer pain, and acute coronary syndromes.


Mechanism of Action (Step-wise)

  1. Morphine binds to μ-opioid receptors (MOR) in the brain and spinal cord.
  2. These receptors are G-protein coupled (Gi/o type).
  3. Activation inhibits adenylate cyclase activity.
  4. This reduces intracellular cyclic AMP (cAMP) levels.
  5. Morphine opens potassium channels, causing K⁺ efflux.
  6. This leads to hyperpolarization of neurons.
  7. It also closes voltage-gated calcium channels (↓ Ca²⁺ influx).
  8. Reduced calcium entry decreases release of excitatory neurotransmitters such as glutamate, substance P, and CGRP.
  9. This inhibits transmission of pain signals in the dorsal horn of the spinal cord.
  10. Morphine also enhances descending inhibitory pain pathways from the brainstem.
  11. The overall effect is decreased perception and transmission of pain (analgesia).

A key exam point is that morphine is a μ-opioid receptor agonist that decreases neurotransmitter release and neuronal excitability.

MOA of Morphine
Mechanism of action of Morphine
Flowchart of mechanism of action of Morphine
Mechanism of Action of Morphine Flowchart

Pharmacokinetics

Morphine can be administered orally, intravenously, intramuscularly, or subcutaneously. It undergoes significant first-pass metabolism, resulting in moderate oral bioavailability. It is metabolized in the liver to active metabolites such as morphine-6-glucuronide. It has a relatively short half-life and requires repeated dosing. Elimination occurs mainly via the kidneys, and accumulation may occur in renal impairment.


Clinical Uses

Morphine is used in the management of severe acute and chronic pain, including postoperative pain, cancer pain, and trauma. It is also used in myocardial infarction to relieve pain and reduce anxiety. In acute pulmonary edema, morphine helps reduce preload and improve symptoms of dyspnea. It is a cornerstone drug in palliative care.


Adverse Effects

Common adverse effects include respiratory depression, sedation, constipation, nausea, vomiting, and miosis. It can cause tolerance and physical dependence with prolonged use. Histamine release may lead to hypotension, flushing, and itching. High doses may result in respiratory arrest, which is the most serious adverse effect.


Comparative Analysis

FeatureMorphineFentanylMethadone
Receptor activityμ-opioid agonistμ-opioid agonistμ-agonist + NMDA antagonist
PotencyModerateVery highModerate
DurationShort–moderateShortLong
Histamine releaseYesMinimalMinimal
UseSevere painAnesthesia, severe painPain, opioid dependence
Active metabolitesYesNoMinimal

Morphine differs from fentanyl in having lower potency and higher histamine release. Compared to methadone, it lacks NMDA receptor antagonism and has a shorter duration of action.


MCQs

  1. Morphine acts primarily on which receptor?
    a) Dopamine receptor
    b) μ-opioid receptor
    c) Serotonin receptor
    d) Histamine receptor

Answer: b) μ-opioid receptor

  1. Morphine inhibits adenylate cyclase, leading to:
    a) Increased cAMP
    b) Decreased cAMP
    c) Increased ATP
    d) No change

Answer: b) Decreased cAMP

  1. Morphine causes hyperpolarization by:
    a) Sodium influx
    b) Potassium efflux
    c) Calcium influx
    d) Chloride influx

Answer: b) Potassium efflux

  1. Morphine decreases neurotransmitter release by reducing:
    a) Sodium
    b) Calcium
    c) Potassium
    d) Chloride

Answer: b) Calcium

  1. Morphine inhibits release of:
    a) Insulin
    b) Substance P
    c) Thyroxine
    d) Cortisol

Answer: b) Substance P

  1. Morphine is used for:
    a) Mild pain
    b) Severe pain
    c) Diabetes
    d) Asthma

Answer: b) Severe pain

  1. A major adverse effect is:
    a) Hypertension
    b) Respiratory depression
    c) Hypercalcemia
    d) Hypoglycemia

Answer: b) Respiratory depression

  1. Morphine causes:
    a) Mydriasis
    b) Miosis
    c) No change in pupils
    d) Diplopia

Answer: b) Miosis

  1. Morphine is metabolized in the:
    a) Kidney
    b) Liver
    c) Lung
    d) Brain

Answer: b) Liver

  1. Morphine may cause:
    a) Hyperactivity
    b) Sedation
    c) Hypercalcemia
    d) Tachycardia

Answer: b) Sedation

  1. Compared to fentanyl, morphine is:
    a) More potent
    b) Less potent
    c) Equal potency
    d) No effect

Answer: b) Less potent

  1. Morphine dependence is due to:
    a) Renal effects
    b) CNS action
    c) Hepatic metabolism
    d) Protein binding

Answer: b) CNS action


FAQs

What is the mechanism of action of morphine?
It activates μ-opioid receptors, decreasing neuronal excitability and neurotransmitter release.

Why does morphine cause respiratory depression?
It depresses the brainstem respiratory centers.

What is a hallmark sign of morphine overdose?
Pinpoint pupils and respiratory depression.

Does morphine cause tolerance?
Yes, especially with prolonged use.

Why does morphine cause constipation?
It reduces gastrointestinal motility.

What is its role in myocardial infarction?
It relieves pain and reduces anxiety and preload.


References

Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Opioids
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191

Katzung: Basic and Clinical Pharmacology – Opioid Analgesics
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382

Tripathi: Essentials of Medical Pharmacology – Opioids
https://www.jaypeedigital.com

Harrison’s Principles of Internal Medicine – Pain Management
https://accessmedicine.mhmedical.com

Author

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators